Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Charles River Laboratories Management to Address UBS Warburg Global Healthcare Services Conference.


Business Editors & Health/Medical Writers

BIOWIRE2K

WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 21, 2003

Charles River Laboratories International, Inc. (NYSE NYSE

See: New York Stock Exchange
:CRL CRL - Carnegie Representation Language.

Carnegie Group, Inc. Frame language derived from SRL. Written in Common LISP. Used in the product Knowledge Craft.
) announced today Senior Vice President and Chief Financial Officer Thomas F. Ackerman will discuss the Company's business outlook at the UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Warburg Global Healthcare Services Conference in New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 on Tuesday, February 4, 2003, at 3:30 p.m. Eastern time.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://www.criver.com. A webcast replay will be accessible through the Investor Relations section of the Company's website approximately three hours following the presentation and will remain available until Tuesday, February 11, 2003. The associated slide presentation will be available for downloading during that time.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 21, 2003
Words:134
Previous Article:Prophet 21 Announces Approval of Merger Agreement; Present Management to Remain in Place as the Company Goes Private.
Next Article:Stellent Reports Third Quarter Financial Results; Company Meets Consensus Analyst Estimates for Pro Forma Net Loss Per Share.



Related Articles
ADVISORY/Bio-Reference Laboratories, Inc. to Present At the UBS Warburg Global Healthcare Services Conference Wednesday, February 7, 2001.
BenefitPoint CEO to Speak at UBS Warburg Global Healthcare Services Conference.
D&K Healthcare to Present On Feb 7, 2002 At UBS Warburg Healthcare Conference in NYC.
ADVISORY/Bio-Reference Laboratories, Inc. to Present At the UBS Warburg Global Healthcare Services Conference Tuesday, February 5, 2002.
Henry Schein to Present At UBS Warburg Global Healthcare Services Conference; Live Webcast to Begin At 10:00 a.m. Eastern Time Tuesday, February 5.
Charles River Laboratories Management to Address UBS Warburg Conference.
Charles River Laboratories Reconfirms Previous Earnings Expectations in Conjunction With UBS Warburg Conference.
Bio-Reference Laboratories, Inc to Speak at the UBS Warburg Global Healthcare Services Conference.
Matria Healthcare to Present at UBS Warburg's Global Healthcare Services Conference.
LCA-Vision to Present at UBS Warburg Global Healthcare Conference; Company Reiterates 2004 EPS Guidance of $0.80 to $0.85.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles